Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study

There is limited epidemiological evidence on outcomes associated with dupilumab exposure during pregnancy; monitoring pregnancy outcomes in large populations is required. To investigate the potential association between exposure to dupilumab in pregnant women with atopic dermatitis and any adverse p...

Ausführliche Beschreibung